Cite
A non-retinol retinoic acid receptor-γ (RAR-γ/NR1B3) selective agonist, tectorigenin, can effectively inhibit the ultraviolet A-induced skin damage.
MLA
Dai, Xintong, et al. “A Non-Retinol Retinoic Acid Receptor-γ (RAR-γ/NR1B3) Selective Agonist, Tectorigenin, Can Effectively Inhibit the Ultraviolet A-Induced Skin Damage.” British Journal of Pharmacology, vol. 179, no. 19, Oct. 2022, pp. 4722–37. EBSCOhost, https://doi.org/10.1111/bph.15902.
APA
Dai, X., Jin, J., Jia, Y., Yang, K., Han, J., Zhang, Z., Ding, X., Yao, C., Sun, T., Zhu, C., & Liu, H. (2022). A non-retinol retinoic acid receptor-γ (RAR-γ/NR1B3) selective agonist, tectorigenin, can effectively inhibit the ultraviolet A-induced skin damage. British Journal of Pharmacology, 179(19), 4722–4737. https://doi.org/10.1111/bph.15902
Chicago
Dai, Xintong, Jing Jin, Yan Jia, Kai Yang, Jingxia Han, Zhiyuan Zhang, Xiujuan Ding, et al. 2022. “A Non-Retinol Retinoic Acid Receptor-γ (RAR-γ/NR1B3) Selective Agonist, Tectorigenin, Can Effectively Inhibit the Ultraviolet A-Induced Skin Damage.” British Journal of Pharmacology 179 (19): 4722–37. doi:10.1111/bph.15902.